Drug Patents owned by Schering

1. Drug name - REBETOL

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6790837 SCHERING Ribavirin syrup formulations Apr, 2023

(5 months from now)

US6790837

(Pediatric)

SCHERING Ribavirin syrup formulations Oct, 2023

(11 months from now)

Drugs and Companies using RIBAVIRIN ingredient

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
40MG/ML SOLUTION;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.